bioRxivCancer Biology
Disseminating cells in human tumours acquire an EMT cancer stem cell state that is predictive of metastasis
G. Youssef, L. Gammon, L. Ambler, S. Lunetto, A. Scemama, H. Cottom, K. Piper, I. C. Mackenzie, M. P. Philpott, A. Biddle
Abstract
Cancer stem cells (CSCs) undergo epithelial-mesenchymal transition (EMT) to drive metastatic dissemination in experimental cancer models. However, tumour cells undergoing EMT have not been observed disseminating into the tissue surrounding human tumour specimens, leaving the relevance to human cancer uncertain. We have previously identified both EpCAM and CD24 as markers of EMT CSCs with enhanced plasticity. This afforded the opportunity to investigate whether retention of EpCAM and CD24 alongside upregulation of the EMT marker Vimentin can identify disseminating EMT CSCs in human tumours. Examining disseminating tumour cells in over 12,000 imaging fields from 84 human oral cancer specimens, we see a significant enrichment of single EpCAM, CD24 and Vimentin co-stained cells disseminating beyond the tumour body in metastatic specimens. Through training an artificial neural network, these predict metastasis with high accuracy (cross-validated accuracy of 87-89%). In this study, we have observed single disseminating EMT CSCs in human oral cancer specimens, and these are highly predictive of metastatic disease.
- organism: human
- assay: imaging
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell-cell communication
- research focus: spatial domain detection
- approach: deep learning
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Acquisition of cancer stem cell properties during EMT requires cell division
P. den Hollander, S. V. Vasaikar, … S. A. Mani·bioRxiv·Jul 1, 2021
- Mesenchymal-epithelial transition in lymph node metastases of oral squamous cell carcinoma is accompanied by ZEB1 expression
K. Horny, C. Sproll, … J. C. Becker·Journal of Translational MedicinePeer-reviewed·Apr 19, 2023
- EMT and MET: necessary or permissive for metastasis?
M. K. Jolly, K. E. Ware, … H. Levine·bioRxiv·Mar 29, 2017
- A mathematical multi-organ model for bidirectional epithelial-mesenchymal transitions in the metastatic spread of cancer
L. C. Franssen, M. A. Chaplain·bioRxiv·Aug 28, 2019
- Malignant and stromal partial EMT programmes and cetuximab outcome in head and neck cancer
Dania Zuhier Ragheb Alkhatib, Sophia Lunetto, … Namshik Han·bioRxiv·Oct 12, 2026
- The 4T1 breast carcinoma model possesses hybrid epithelial/mesenchymal traits linked to a highly metastatic phenotype
Mary E. Herndon, Katherine Gibson-Corley, … Christopher S. Stipp·bioRxiv·Feb 2, 2024